SCHEMBL971189

SCHEMBL971189

COC(=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3202722 0.97
Urea SCHEMBL11495730 0.81 ALDH1A1 (0.47)
SCHEMBL8295 0.76
SCHEMBL6950834 0.76 ALDH1A1 (0.56)
SCHEMBL344664 0.76
SCHEMBL15144423 0.76
SCHEMBL10500046 0.74 ALDH1A1 (0.36)
SCHEMBL10542559 0.74 ALDH1A1 (0.79)
SCHEMBL209024 0.73
SCHEMBL2592313 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118530132-A Preparation method of N-acyl amino acid surfactant 盐城工学院 2024-08-23 CN claimed
CN-116768906-B Tri-fused ring compound and preparation method and application thereof 遵义医科大学珠海校区 2024-04-09 CN claimed
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US claimed
CN-115485259-A Substituted hydroxystilbene compounds and derivatives, synthesis and use thereof 凯楠公爵IP有限责任公司 2022-12-16 CN claimed
WO-2021127743-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2021-07-01 WO claimed
CN-107033157-B Bisbenzylisoquinoline derivative and application thereof in preparing medicament for treating or preventing tumor 贵州省中国科学院天然产物化学重点实验室 2020-05-05 CN claimed
US-10189812-B2 Bi-benzyl isoquinoline derivative, preparation method and use thereof in hepatopathy treatment and prevention THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUC (CN) 2019-01-29 US claimed
CN-107207524-A Bisbenzylisoquinolinderivative derivative, its preparation method and its purposes in the treatment and prevention of hepatopathy 贵州省中国科学院天然产物化学重点实验室 2017-09-26 CN claimed
US-20170260161-A1 BI-BENZYL ISOQUINOLINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF IN HEPATOPATHY TREATMENT AND PREVENTION VERSITECH LIMITED (CN) 2017-09-14 US claimed
CN-107033157-A Bisbenzylisoquinolinderivative derivative and its purposes in preparing for treating or preventing the medicine of tumour 贵州省中国科学院天然产物化学重点实验室 2017-08-11 CN claimed
WO-2005082347-A1 USE OF METHYLENE AMIDE DERIVATIVES IN CARDIOVASCULAR DISORDERS APLLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-09-09 WO claimed
EP-1146788-A4 AMIDE DERIVATIVES FOR ANTIANGIOGENIC AND/OR ANTITUMORIGENIC USE UNIV VANDERBILT (US) 2003-09-10 EP claimed
EP-1148783-A4 CONVERTING COX INHIBITION COMPOUNDS THAT ARE NOT COX-2 SELECTIVE INHIBITORS TO DERIVATIVES THAT ARE COX-2 SELECTIVE INHIBITORS UNIV VANDERBILT (US) 2003-05-21 EP claimed
EP-1148783-A1 CONVERTING COX INHIBITION COMPOUNDS THAT ARE NOT COX-2 SELECTIVE INHIBITORS TO DERIVATIVES THAT ARE COX-2 SELECTIVE INHIBITORS Vanderbilt University (US) 2001-10-31 EP claimed
EP-1146788-A1 AMIDE DERIVATIVES FOR ANTIANGIOGENIC AND/OR ANTITUMORIGENIC USE Vanderbilt University (US) 2001-10-24 EP claimed
WO-2000040087-A1 CONVERTING COX INHIBITION COMPOUNDS THAT ARE NOT COX-2 SELECTIVE INHIBITORS TO DERIVATIVES THAT ARE COX-2 SELECTIVE INHIBITORS VANDERBILT UNIVERSITY (US) 2000-07-13 WO claimed
WO-2000040088-A1 AMIDE DERIVATIVES FOR ANTIANGIOGENIC AND/OR ANTITUMORIGENIC USE VANDERBILT UNIVERSITY (US) 2000-07-13 WO claimed
EP-0001914-B1 ANTIBACTERIALLY ACTIVE AMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID AMIDES BEECHAM GROUP PLC (GB) 1981-05-20 EP claimed
US-4200635-A MONIC ACID A AMIDES BEECHAM GROUP LIMITED (GB) 1980-04-29 US claimed
EP-0001914-A2 Antibacterially active amides, process for their preparation and pharmaceutical compositions containing said amides BEECHAM GROUP PLC (GB) 1979-05-16 EP claimed